Osteoarthritic Tarsometatarsal Joint Treatment

12 Year old Warmblood Gelding:

Devon was a 12-year-old Warmblood gelding that was competing at level 5 dressage. Over the space of three months his ability to perform flying changes to the left significantly reduced and his willingness to conduct upwards, transitions deteriorated. (continue)

 

Joint Lameness:

Physical examination found the horse to be 3/5 lame in the left hind leg, which was isolated to the tarsometatarsal (lower hock) joint with diagnostic analgesia. Radiographs were taken and found there to be mild osteoarthritic change on the front of the tarsometatarsal joint, with there being a reduction in bone density and slight spur development, which is shown in the image, left, within the green circle.

Treatment and Outcome: 

1ml of Arthramid® Vet was injected into the joint and the horse was then rested for 48 hours before commencing an ascending exercise program over two weeks to return to a full exercise regime. Over the space of four weeks, the clinical signs dissipated with the horse willingly and comfortably able to perform all movements asked of it. Devon was injected eight months previously and continues to show no recurrence of clinical signs of pain and has one delighted owner as a result.

Our Manufacturing Policy

Every detail is taken care of

We realised early on that quality assurance is everything when you need a product that an animal’s health and well-being relies on. We needed to know every step of the manufacturing process; to ensure the quality and integrity of our products. All materials are stored at a constant temperature and humidity to ensure consistency within manufacturers recommendations. We want to make sure every detail is taken care of in the best way possible and we only work with suppliers that hold the same values.

JOINT LAMENESS & OSTEOARTHRITIS

Osteoarthritis (OA) is considered one of the most important musculoskeletal disorders in both humans and horses.

CLINICAL SAFETY IN APPLICATION

Both in vitro and in vivo studies have taken place, of Arthramid Vet to support regulatory submissions for market authorisation.

Industry Changing Innovations

Integrity in every product

For professional athletes, both human and equine alike, banned substance testing carries fear for even those riders and trainers making every effort to stay compliant. We want to ensure the integrity of every product we recommend meets local racing and regulatory authority requirements with the finished product being extensively tested for quality, potency and banned substances.

Get In Touch

I am Interested In

Order Request

32 Hill Road, Cambridge, NZ
Phone +64 (09) 8013 253
E: sales@imsvet.com

Innovative Medical Solutions

Registered in New Zealand to: Innovative Medical Solutions Limited NZBN: 9429041325544, 32 Hill Road, Cambridge 3494, New Zealand. Registered pursuant to the ACVM Act 1997 Number A11596. See www.foodsafety.govt.nz  for registration conditions.

32 Hill Road, Cambridge
PO Box 1083, Cambridge 3450
Phone +64 (09) 8013 253
sales@imsvet.com